Nina Škottová

1.0k total citations
35 papers, 893 citations indexed

About

Nina Škottová is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nina Škottová has authored 35 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nina Škottová's work include Silymarin and Mushroom Poisoning (14 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Hormonal and reproductive studies (6 papers). Nina Škottová is often cited by papers focused on Silymarin and Mushroom Poisoning (14 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Hormonal and reproductive studies (6 papers). Nina Škottová collaborates with scholars based in Czechia, Sweden and Slovakia. Nina Škottová's co-authors include Rostislav Večeřa, Vilı́m Šimánek, Aivar Lõokene, Gunilla Olivecrona, Jitka Ulrichová, Karel Urbánek, Daniela Walterová, Magnus Hultin, Ladislav Cvak and Ludmila Kazdová and has published in prestigious journals such as Biochemical Journal, Journal of Lipid Research and European Journal of Biochemistry.

In The Last Decade

Nina Škottová

35 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Škottová Czechia 16 368 304 281 193 148 35 893
Argelia Garrido Chile 15 287 0.8× 297 1.0× 216 0.8× 90 0.5× 75 0.5× 31 980
Tianqi Wang China 13 97 0.3× 119 0.4× 459 1.6× 145 0.8× 74 0.5× 30 1.2k
Víctor Pérez-Álvarez Mexico 13 98 0.3× 369 1.2× 177 0.6× 74 0.4× 82 0.6× 30 844
E. Bosisio Italy 14 96 0.3× 126 0.4× 232 0.8× 67 0.3× 130 0.9× 38 714
Hongming Lv China 17 113 0.3× 387 1.3× 804 2.9× 52 0.3× 97 0.7× 22 1.4k
Xiaqing Wu China 17 83 0.2× 81 0.3× 413 1.5× 248 1.3× 89 0.6× 22 1.1k
MOHAMED H. ABDEL-WAHAB Egypt 8 55 0.1× 188 0.6× 193 0.7× 57 0.3× 89 0.6× 9 1.1k
A. Esteller Spain 16 49 0.1× 172 0.6× 271 1.0× 110 0.6× 88 0.6× 66 1.2k
Shuhei Sakaguchi Japan 16 43 0.1× 223 0.7× 277 1.0× 97 0.5× 59 0.4× 55 993
Kuei‐Chuan Chan Taiwan 22 43 0.1× 409 1.3× 476 1.7× 219 1.1× 80 0.5× 57 1.5k

Countries citing papers authored by Nina Škottová

Since Specialization
Citations

This map shows the geographic impact of Nina Škottová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Škottová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Škottová more than expected).

Fields of papers citing papers by Nina Škottová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Škottová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Škottová. The network helps show where Nina Škottová may publish in the future.

Co-authorship network of co-authors of Nina Škottová

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Škottová. A scholar is included among the top collaborators of Nina Škottová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Škottová. Nina Škottová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anzenbacherová, Eva, et al.. (2012). Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats. Xenobiotica. 42(8). 731–736. 12 indexed citations
2.
Večeřa, Rostislav, et al.. (2011). The effect of silymarin on expression of selected ABC transporters in the rat. Veterinární Medicína. 56(2). 59–62. 13 indexed citations
3.
Večeřa, Rostislav, et al.. (2011). Fenofibrate‐induced decrease of expression of CYP2C11 and CYP2C6 in rat. Biopharmaceutics & Drug Disposition. 32(8). 482–487. 29 indexed citations
4.
Večeřa, Rostislav, et al.. (2007). The Influence of Maca (Lepidium meyenii) on Antioxidant Status, Lipid and Glucose Metabolism in Rat. Plant Foods for Human Nutrition. 62(2). 59–63. 60 indexed citations
5.
Večeřa, Rostislav, et al.. (2007). Hypolipidemic effects of silymarin are not mediated by the peroxisome proliferator-activated receptor alpha. Xenobiotica. 37(7). 725–735. 12 indexed citations
6.
Škottová, Nina, et al.. (2005). Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats. Pharmacological Research. 53(2). 104–112. 83 indexed citations
7.
Švagera, Zdeněk, Nina Škottová, Rostislav Večeřa, et al.. (2003). Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum. Phytotherapy Research. 17(5). 524–530. 24 indexed citations
8.
Škottová, Nina, et al.. (2003). Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacological Research. 47(1). 17–26. 73 indexed citations
10.
Šimánek, Vilı́m, J. Vičar, Vladimı́r Křen, et al.. (2001). ["Silymarin"--an extract from the milk thistle (Silybum marianum)--is it a drug or nutritional supplement?].. PubMed. 50(2). 66–9. 3 indexed citations
11.
Šimánek, Vilı́m, Petr Sedmera, Petr Halada, et al.. (2001). Chemoenzymatic Preparation of Oligoglycosides of Silybin, the Flavonolignan from Silybum marianum. Heterocycles. 54(2). 901–901. 13 indexed citations
12.
Škottová, Nina, et al.. (2001). Pharmacokinetic study of iodine-labeled silibinins in rat. Pharmacological Research. 44(3). 247–253. 21 indexed citations
13.
Šimánek, Vilı́m, Nina Škottová, Jitka Ulrichová, et al.. (2001). Perspective [Prospective] nutraceutical - milk thistle extract with polyunsaturated fatty acids.. 65–68. 1 indexed citations
14.
Škottová, Nina, et al.. (1995). Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver.. Journal of Lipid Research. 36(6). 1334–1344. 58 indexed citations
15.
Lõokene, Aivar, Nina Škottová, & Gunilla Olivecrona. (1994). Interactions of lipoprotein lipase with the active‐site inhibitor tetrahydrolipstatin (Orlistat)R. European Journal of Biochemistry. 222(2). 395–403. 112 indexed citations
16.
Giménez‐Llort, Lydia, et al.. (1991). Lipoprotein lipase enables triacylglycerol hydrolysis by perfused newborn rat liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. 261(4). G641–G647. 9 indexed citations
17.
Lasunción, Miguel A., A Iglesias, Nina Škottová, Esther Orozco, & Emílio Herrera. (1990). High-density lipoprotein subpopulations as substrates for the transfer of cholesteryl esters to very-low-density lipoproteins. Biochemical Journal. 270(2). 441–449. 18 indexed citations
18.
Škottová, Nina, Lars Wallinder, & Gunilla Bengtsson. (1983). Activity of lipoprotein lipase in thyroidectomized rats. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 750(3). 533–538. 7 indexed citations
19.
Macho, L, et al.. (1981). Metabolic changes in rats subjected to space flight for 18.5 days in the biosatellite Cosmos 936. Advances in Space Research. 1(14). 219–224. 9 indexed citations
20.
Škottová, Nina, et al.. (1976). Blood Lipids during Normal and Early Weaning in Rats. Neonatology. 29(5-6). 274–280. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026